Trial Profile
Phase III trial of SABER-bupivacaine (Posidur) for pain relief in patients with soft tissue injuries
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain; Soft tissue injuries
- Focus Adverse reactions; Registrational
- Sponsors DURECT Corporation
- 26 May 2015 New trial record